Notably, BMP2 inhibition effectively suppressed MSC-mediated tumor growth by abrogating cancer stem cell properties in a xenograft mouse model, indicating that ovarian cancer-associated MSCs promote an aggressive ovarian cancer phenotype by regulating cancer stem cell function and that BMP2 inhibition may be an attractive therapeutic approach for ovarian cancer metastasis [71]. This evidence concerns the gene BMP2 and cancer.